Recombinant Human Parathyroid Hormone - Global and China Top Players Market Share and Ranking 2023
Recombinant Human Parathyroid Hormone - Global and China Top Players Market Share and Ranking 2023
Insights into the Recombinant Human Parathyroid Hormone Market include supply chain optimization, Recombinant Human Parathyroid Hormone challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest study , the global market for Recombinant Human Parathyroid Hormone should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Recombinant Human Parathyroid Hormone market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Recombinant Human Parathyroid Hormone market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Postmenopausal Women with Osteoporosis grew percent to account for percent of the total market sales, and Hypocalcemia in Patients with Hypoparathyroidism grew percent.
This report studies and analyses global Recombinant Human Parathyroid Hormone status and future trends, helps the client to determine the Recombinant Human Parathyroid Hormone market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Recombinant Human Parathyroid Hormone, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Recombinant Human Parathyroid Hormone market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Recombinant Human Parathyroid Hormone sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Recombinant Human Parathyroid Hormone sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Recombinant Human Parathyroid Hormone key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Recombinant Human Parathyroid Hormone key producing regions, capacity, production, and year over year growth
(6) Recombinant Human Parathyroid Hormone industry chains, upstream, midstream and downstream
Market segment by players, this report covers
NPS Pharma(Shire)
Takeda
Shandong Buchang Pharmaceuticals
Ascendis Pharma
Beijing SL Pharmaceutical
Market segment by Type, covers
25 mcg/dose
50 mcg/dose
75 mcg/dose
100 mcg/dose
Market segment by Application, can be divided into
Postmenopausal Women with Osteoporosis
Hypocalcemia in Patients with Hypoparathyroidism
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Recombinant Human Parathyroid Hormone product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Recombinant Human Parathyroid Hormone market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Recombinant Human Parathyroid Hormone market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Recombinant Human Parathyroid Hormone, percent & CAGR, 2018-2029
Chapter 5: Recombinant Human Parathyroid Hormone industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Recombinant Human Parathyroid Hormone Definition
1.2 Global Recombinant Human Parathyroid Hormone Market Size and Forecast
1.2.1 By Consumption Value, Global Recombinant Human Parathyroid Hormone Market Size，2018-2029
1.2.2 By Sales Quantity, Global Recombinant Human Parathyroid Hormone Market Size，2018-2029
1.2.3 Global Recombinant Human Parathyroid Hormone Average Selling Price (ASP)，2018-2029
1.3 China Recombinant Human Parathyroid Hormone Market Size and Forecast
1.3.1 By Consumption Value, China Recombinant Human Parathyroid Hormone Market Size，2018-2029
1.3.2 By Sales Quantity, China Recombinant Human Parathyroid Hormone Market Size，2018-2029
1.3.3 China Recombinant Human Parathyroid Hormone Average Selling Price (ASP)， 2018-2029
1.4 Share of China Recombinant Human Parathyroid Hormone Market with Respect to the Global Market
1.4.1 By Consumption Value, China Recombinant Human Parathyroid Hormone Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Recombinant Human Parathyroid Hormone Market Share in Global, 2018-2029
1.4.3 Recombinant Human Parathyroid Hormone Market Size: China VS Global, 2018-2029
1.5 Recombinant Human Parathyroid Hormone Market Dynamics
1.5.1 Recombinant Human Parathyroid Hormone Market Drivers
1.5.2 Recombinant Human Parathyroid Hormone Market Restraints
1.5.3 Recombinant Human Parathyroid Hormone Industry Trends
1.5.4 Recombinant Human Parathyroid Hormone Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Recombinant Human Parathyroid Hormone, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Recombinant Human Parathyroid Hormone, Global Market Share by Company, 2018-2023
2.3 Recombinant Human Parathyroid Hormone Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Recombinant Human Parathyroid Hormone Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Recombinant Human Parathyroid Hormone Concentration Ratio
2.6 Global Recombinant Human Parathyroid Hormone Mergers & Acquisitions, Expansion Plans
2.7 Global Recombinant Human Parathyroid Hormone Manufacturers Product Type
2.8 Head Office and Recombinant Human Parathyroid Hormone Production Site of Key Manufacturer
2.9 Recombinant Human Parathyroid Hormone Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Recombinant Human Parathyroid Hormone, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Recombinant Human Parathyroid Hormone, China Market Share by Company, 2018-2023
3.3 China Recombinant Human Parathyroid Hormone Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Recombinant Human Parathyroid Hormone Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Recombinant Human Parathyroid Hormone Capacity by Region
4.3 Global Recombinant Human Parathyroid Hormone Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Recombinant Human Parathyroid Hormone Production by Region, 2018-2029
4.5 Global Recombinant Human Parathyroid Hormone Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Recombinant Human Parathyroid Hormone Industry Chain
5.2 Recombinant Human Parathyroid Hormone Upstream Analysis
5.2.1 Recombinant Human Parathyroid Hormone Core Raw Materials
5.2.2 Main Manufacturers of Recombinant Human Parathyroid Hormone Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Recombinant Human Parathyroid Hormone Production Mode
5.6 Recombinant Human Parathyroid Hormone Procurement Model
5.7 Recombinant Human Parathyroid Hormone Industry Sales Model and Sales Channels
5.7.1 Recombinant Human Parathyroid Hormone Sales Model
5.7.2 Recombinant Human Parathyroid Hormone Typical Distributors
6 Sights by Type
6.1 Recombinant Human Parathyroid Hormone Classification
6.1.1 25 mcg/dose
6.1.2 50 mcg/dose
6.1.3 75 mcg/dose
6.1.4 100 mcg/dose
6.2 By Type, Global Recombinant Human Parathyroid Hormone Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029
6.4 By Type, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029
6.5 By Type, Global Recombinant Human Parathyroid Hormone Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Recombinant Human Parathyroid Hormone Segment by Application
7.1.1 Postmenopausal Women with Osteoporosis
7.1.2 Hypocalcemia in Patients with Hypoparathyroidism
7.2 By Application, Global Recombinant Human Parathyroid Hormone Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029
7.4 By Application, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029
7.5 By Application, Global Recombinant Human Parathyroid Hormone Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029
8.3 By Region, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Recombinant Human Parathyroid Hormone & Forecasts, 2018-2029
8.4.2 By Country, North America Recombinant Human Parathyroid Hormone Market Size Market Share
8.5 Europe
8.5.1 Europe Recombinant Human Parathyroid Hormone Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Recombinant Human Parathyroid Hormone Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Recombinant Human Parathyroid Hormone Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Recombinant Human Parathyroid Hormone Market Size Market Share
8.7 South America
8.7.1 South America Recombinant Human Parathyroid Hormone Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Recombinant Human Parathyroid Hormone Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Recombinant Human Parathyroid Hormone Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029
9.3 By Country, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.4.2 By Type, U.S. Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.5.2 By Type, Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.6.2 By Type, China Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.7.2 By Type, Japan Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.8.2 By Type, South Korea Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.10.2 By Type, India Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Recombinant Human Parathyroid Hormone Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 NPS Pharma(Shire)
10.1.1 NPS Pharma(Shire) Company Information, Head Office, Market Area, and Industry Position
10.1.2 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Models, Specifications, and Application
10.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 NPS Pharma(Shire) Company Profile and Main Business
10.1.5 NPS Pharma(Shire) Recent Developments
10.2 Takeda
10.2.1 Takeda Company Information, Head Office, Market Area, and Industry Position
10.2.2 Takeda Recombinant Human Parathyroid Hormone Models, Specifications, and Application
10.2.3 Takeda Recombinant Human Parathyroid Hormone Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Takeda Company Profile and Main Business
10.2.5 Takeda Recent Developments
10.3 Shandong Buchang Pharmaceuticals
10.3.1 Shandong Buchang Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.3.2 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Models, Specifications, and Application
10.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Shandong Buchang Pharmaceuticals Company Profile and Main Business
10.3.5 Shandong Buchang Pharmaceuticals Recent Developments
10.4 Ascendis Pharma
10.4.1 Ascendis Pharma Company Information, Head Office, Market Area, and Industry Position
10.4.2 Ascendis Pharma Recombinant Human Parathyroid Hormone Models, Specifications, and Application
10.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Ascendis Pharma Company Profile and Main Business
10.4.5 Ascendis Pharma Recent Developments
10.5 Beijing SL Pharmaceutical
10.5.1 Beijing SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Models, Specifications, and Application
10.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Beijing SL Pharmaceutical Company Profile and Main Business
10.5.5 Beijing SL Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Recombinant Human Parathyroid Hormone Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Recombinant Human Parathyroid Hormone Market Restraints
Table 3. Recombinant Human Parathyroid Hormone Market Trends
Table 4. Recombinant Human Parathyroid Hormone Industry Policy
Table 5. Global Recombinant Human Parathyroid Hormone Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Recombinant Human Parathyroid Hormone Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Recombinant Human Parathyroid Hormone Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Recombinant Human Parathyroid Hormone Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Recombinant Human Parathyroid Hormone Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Recombinant Human Parathyroid Hormone Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Recombinant Human Parathyroid Hormone Mergers & Acquisitions, Expansion Plans
Table 12. Global Recombinant Human Parathyroid Hormone Manufacturers Product Type
Table 13. Head Office and Recombinant Human Parathyroid Hormone Production Site of Key Manufacturer
Table 14. Recombinant Human Parathyroid Hormone Capacity of Major Manufacturers and Future Plan
Table 15. China Recombinant Human Parathyroid Hormone Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Recombinant Human Parathyroid Hormone Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Recombinant Human Parathyroid Hormone Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Recombinant Human Parathyroid Hormone Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Recombinant Human Parathyroid Hormone Production by Region, 2018-2023, (K Units)
Table 20. Global Recombinant Human Parathyroid Hormone Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Recombinant Human Parathyroid Hormone Upstream (Raw Materials)
Table 22. Global Recombinant Human Parathyroid Hormone Typical Customers
Table 23. Recombinant Human Parathyroid Hormone Typical Distributors
Table 24. By Type, Global Recombinant Human Parathyroid Hormone Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Recombinant Human Parathyroid Hormone Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Recombinant Human Parathyroid Hormone Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2018-2029
Table 34. NPS Pharma(Shire) Company Information, Head Office, Market Area, and Industry Position
Table 35. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Models, Specifications, and Application
Table 36. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. NPS Pharma(Shire) Company Profile and Main Business
Table 38. NPS Pharma(Shire) Recent Developments
Table 39. Takeda Company Information, Head Office, Market Area, and Industry Position
Table 40. Takeda Recombinant Human Parathyroid Hormone Models, Specifications, and Application
Table 41. Takeda Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Takeda Company Profile and Main Business
Table 43. Takeda Recent Developments
Table 44. Shandong Buchang Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 45. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Models, Specifications, and Application
Table 46. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Shandong Buchang Pharmaceuticals Company Profile and Main Business
Table 48. Shandong Buchang Pharmaceuticals Recent Developments
Table 49. Ascendis Pharma Company Information, Head Office, Market Area, and Industry Position
Table 50. Ascendis Pharma Recombinant Human Parathyroid Hormone Models, Specifications, and Application
Table 51. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Ascendis Pharma Company Profile and Main Business
Table 53. Ascendis Pharma Recent Developments
Table 54. Beijing SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 55. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Models, Specifications, and Application
Table 56. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Beijing SL Pharmaceutical Company Profile and Main Business
Table 58. Beijing SL Pharmaceutical Recent Developments
List of Figures
Figure 1. Recombinant Human Parathyroid Hormone Picture
Figure 2. Global Recombinant Human Parathyroid Hormone Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Recombinant Human Parathyroid Hormone Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Recombinant Human Parathyroid Hormone Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Recombinant Human Parathyroid Hormone Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Recombinant Human Parathyroid Hormone Sales Quantity (K Units) & (2018-2029)
Figure 7. China Recombinant Human Parathyroid Hormone Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Recombinant Human Parathyroid Hormone Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Recombinant Human Parathyroid Hormone Market Share of Global, 2018-2029
Figure 10. Global Recombinant Human Parathyroid Hormone Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Recombinant Human Parathyroid Hormone Key Participants, Market Share, 2022
Figure 12. Global Recombinant Human Parathyroid Hormone Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Recombinant Human Parathyroid Hormone Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Recombinant Human Parathyroid Hormone Production Market Share & Forecast by Region, 2018-2029
Figure 15. Recombinant Human Parathyroid Hormone Industry Chain
Figure 16. Recombinant Human Parathyroid Hormone Procurement Model
Figure 17. Recombinant Human Parathyroid Hormone Sales Model
Figure 18. Recombinant Human Parathyroid Hormone Sales Channels, Direct Sales, and Distribution
Figure 19. 25 mcg/dose
Figure 20. 50 mcg/dose
Figure 21. 75 mcg/dose
Figure 22. 100 mcg/dose
Figure 23. By Type, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Recombinant Human Parathyroid Hormone Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Postmenopausal Women with Osteoporosis
Figure 29. Hypocalcemia in Patients with Hypoparathyroidism
Figure 30. By Application, Global Recombinant Human Parathyroid Hormone Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Recombinant Human Parathyroid Hormone Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2018-2029
Figure 37. North America Recombinant Human Parathyroid Hormone Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2022
Figure 39. Europe Recombinant Human Parathyroid Hormone Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2022
Figure 41. Asia Pacific Recombinant Human Parathyroid Hormone Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2022
Figure 43. South America Recombinant Human Parathyroid Hormone Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Recombinant Human Parathyroid Hormone Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Research Methodology:
Recombinant Human Parathyroid Hormone Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|